IONS - Ionis Pharmaceuticals files to sell ordinary shares
2023-11-24 14:16:08 ET
More on Ionis Pharmaceuticals
- Ionis Pharmaceuticals, Inc. (IONS) Q3 2023 Earnings Call Transcript
- Ionis Pharmaceuticals: Mid-Sized Pharma Is A Strong Buy Opportunity For All-Comers
- Ionis says Angelman syndrome drug well tolerated in study
- Ionis Pharmaceuticals GAAP EPS of -$1.03 in-line, revenue of $144M beats by $7.62M
For further details see:
Ionis Pharmaceuticals files to sell ordinary shares